{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T13:59:51Z","timestamp":1694699991265},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2261-12-84","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T14:14:16Z","timestamp":1349187256000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry"],"prefix":"10.1186","volume":"12","author":[{"given":"Michael","family":"Maeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisette Okkels","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kaltoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Henrik","family":"Tilsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evald H\u00f8j","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Thayssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Flensted","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Thuesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,2]]},"reference":[{"key":"511_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O\u2019Shaughnessy C, et al: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003, 349: 1315-1323. 10.1056\/NEJMoa035071.","journal-title":"N Engl J Med"},{"key":"511_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, Hermiller J, O\u2019Shaughnessy C, Mann JT, et al: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004, 350: 221-231. 10.1056\/NEJMoa032441.","journal-title":"N Engl J Med"},{"key":"511_CR3","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.jacc.2008.01.056","volume":"51","author":"H Kelbaek","year":"2008","unstructured":"Kelbaek H, Klovgaard L, Helqvist S, Lassen JF, Krusell LR, Engstrom T, et al: Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress\/Benestent Disease) trial. J Am Coll Cardiol. 2008, 51: 2011-2016. 10.1016\/j.jacc.2008.01.056.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jacc.2008.09.058","volume":"53","author":"A Kaltoft","year":"2008","unstructured":"Kaltoft A, Jensen LO, Maeng M, Tilsted HH, Thayssen P, Bottcher M, et al: Two-Year Clinical Outcomes after Implantation of Coronary Sirolimus- and Paclitaxel-eluting Stents and Bare Metal Stents in Western Denmark. J Am Coll Cardiol. 2008, 53: 658-664.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/CIRCULATIONAHA.108.781377","volume":"118","author":"L Mauri","year":"2008","unstructured":"Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, et al: Long-term clinical outcomes after drug-eluting and bare-metal stenting in massachusetts. Circulation. 2008, 118: 1817-1827. 10.1161\/CIRCULATIONAHA.108.781377.","journal-title":"Circulation"},{"key":"511_CR6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa071076","volume":"357","author":"JV Tu","year":"2007","unstructured":"Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, et al: Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med. 2007, 357: 1393-1402. 10.1056\/NEJMoa071076.","journal-title":"N Engl J Med"},{"key":"511_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al: Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007, 369: 667-678. 10.1016\/S0140-6736(07)60314-6.","journal-title":"Lancet"},{"key":"511_CR8","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","volume":"115","author":"S Cook","year":"2007","unstructured":"Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al: Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007, 115: 2426-2434. 10.1161\/CIRCULATIONAHA.106.658237.","journal-title":"Circulation"},{"key":"511_CR9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","volume":"27","author":"AV Finn","year":"2007","unstructured":"Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al: Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007, 27: 1500-1510. 10.1161\/ATVBAHA.107.144220.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"511_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.amjcard.2007.04.016","volume":"100","author":"R Sakurai","year":"2007","unstructured":"Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, et al: Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol. 2007, 100: 818-823. 10.1016\/j.amjcard.2007.04.016.","journal-title":"Am J Cardiol"},{"key":"511_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ahj.2007.08.008","volume":"155","author":"A Miyazawa","year":"2008","unstructured":"Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, et al: Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Am Heart J. 2008, 155: 108-113. 10.1016\/j.ahj.2007.08.008.","journal-title":"Am Heart J"},{"key":"511_CR12","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.107.752261","volume":"117","author":"TL Pinto Slottow","year":"2008","unstructured":"Pinto Slottow TL, Waksman R: Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the endeavor zotarolimus-eluting coronary stent. Circulation. 2008, 117: 1603-1608. 10.1161\/CIRCULATIONAHA.107.752261.","journal-title":"Circulation"},{"key":"511_CR13","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S0142-9612(01)00297-6","volume":"23","author":"AL Lewis","year":"2002","unstructured":"Lewis AL, Tolhurst LA, Stratford PW: Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials. 2002, 23: 1697-1706. 10.1016\/S0142-9612(01)00297-6.","journal-title":"Biomaterials"},{"key":"511_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/hrt.2007.139261","volume":"95","author":"M Maeng","year":"2009","unstructured":"Maeng M, Jensen LO, Falk E, Andersen HR, Thuesen L: Negative vascular remodelling after implantation of bioabsorbable magnesium alloy stents in porcine coronary arteries: a randomised comparison with bare-metal and sirolimus-eluting stents. Heart. 2009, 95: 241-246.","journal-title":"Heart"},{"key":"511_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjcard.2008.09.084","volume":"103","author":"M Maeng","year":"2009","unstructured":"Maeng M, Jensen LO, Galloe AM, Thayssen P, Christiansen EH, Hansen KN, et al: Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial. Am J Cardiol. 2009, 103: 345-349. 10.1016\/j.amjcard.2008.09.084.","journal-title":"Am J Cardiol"},{"key":"511_CR16","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehn434","volume":"29","author":"LO Jensen","year":"2008","unstructured":"Jensen LO, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Galloe A, et al: Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. Eur Heart J. 2008, 29: 2733-2741. 10.1093\/eurheartj\/ehn434.","journal-title":"Eur Heart J"},{"key":"511_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMoa044372","volume":"353","author":"A Dibra","year":"2005","unstructured":"Dibra A, Kastrati A, Mehilli J, Pache J, Sch hlen H, von Beckerath N, et al: Paclitaxel-eluting or Sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005, 353: 663-670. 10.1056\/NEJMoa044372.","journal-title":"N Engl J Med"},{"key":"511_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","volume":"52","author":"M Joner","year":"2008","unstructured":"Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, et al: Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008, 52: 333-342. 10.1016\/j.jacc.2008.04.030.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR19","doi-asserted-by":"publisher","first-page":"36M","DOI":"10.1016\/j.amjcard.2007.08.020","volume":"100","author":"G Nakazawa","year":"2007","unstructured":"Nakazawa G, Finn AV, John MC, Kolodgie FD, Virmani R: The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. Am J Cardiol. 2007, 100: 36M-44M. 10.1016\/j.amjcard.2007.08.020.","journal-title":"Am J Cardiol"},{"key":"511_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/hep.21404","volume":"44","author":"HT S\u00f8rensen","year":"2006","unstructured":"S\u00f8rensen HT, Lash TL, Rothman KJ: Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology. 2006, 44: 1075-1082. 10.1002\/hep.21404.","journal-title":"Hepatology"},{"key":"511_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jacc.2007.06.002","volume":"50","author":"LO Jensen","year":"2007","unstructured":"Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, et al: Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol. 2007, 50: 463-470. 10.1016\/j.jacc.2007.06.002.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1056\/NEJMoa067731","volume":"356","author":"L Mauri","year":"2007","unstructured":"Mauri L, Hsieh WH, Massaro JM, Ho KK, D\u2019Agostino R, Cutlip DE: Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007, 356: 1020-1029. 10.1056\/NEJMoa067731.","journal-title":"N Engl J Med"},{"key":"511_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","volume":"90","author":"H Tunstall-Pedoe","year":"1994","unstructured":"Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A: Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994, 90: 583-612. 10.1161\/01.CIR.90.1.583.","journal-title":"Circulation"},{"key":"511_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"511_CR25","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","volume":"375","author":"K Rasmussen","year":"2010","unstructured":"Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, et al: Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet. 2010, 375: 1090-1099. 10.1016\/S0140-6736(10)60208-5.","journal-title":"Lancet"},{"key":"511_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1136\/hrt.2009.167759","volume":"95","author":"JS Kim","year":"2009","unstructured":"Kim JS, Jang IK, Kim JS, Kim TH, Takano M, Kume T, et al: Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart. 2009, 95: 1907-1912. 10.1136\/hrt.2009.167759.","journal-title":"Heart"},{"key":"511_CR27","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2006.08.035","volume":"48","author":"DE Kandzari","year":"2006","unstructured":"Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O\u2019Shaughnessy C, Ball MW, et al: Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol. 2006, 48: 2440-2447. 10.1016\/j.jacc.2006.08.035.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR28","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jacc.2009.01.054","volume":"53","author":"O Frobert","year":"2009","unstructured":"Frobert O, Lagerqvist B, Carlsson J, Lindback J, Stenestrand U, James SK: Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). J Am Coll Cardiol. 2009, 53: 1660-1667. 10.1016\/j.jacc.2009.01.054.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jacc.2010.03.086","volume":"56","author":"DW Park","year":"2010","unstructured":"Park DW, Kim YH, Yun SC, Kang SJ, Lee SW, Lee CW, et al: Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial. J Am Coll Cardiol. 2010, 56: 1187-1195. 10.1016\/j.jacc.2010.03.086.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR30","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.amjcard.2009.06.059","volume":"104","author":"CW Lee","year":"2009","unstructured":"Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, et al: Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Am J Cardiol. 2009, 104: 1370-1376. 10.1016\/j.amjcard.2009.06.059.","journal-title":"Am J Cardiol"},{"key":"511_CR31","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/eurheartj\/ehp044","volume":"30","author":"RA Byrne","year":"2009","unstructured":"Byrne RA, Mehilli J, Iijima R, Schulz S, Pache J, Seyfarth M, et al: A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents. Eur Heart J. 2009, 30: 923-931.","journal-title":"Eur Heart J"},{"key":"511_CR32","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1161\/CIRCULATIONAHA.104.513952","volume":"111","author":"L Mauri","year":"2005","unstructured":"Mauri L, Orav EJ, Kuntz RE: Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005, 111: 3435-3442. 10.1161\/CIRCULATIONAHA.104.513952.","journal-title":"Circulation"},{"key":"511_CR33","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1161\/CIRCULATIONAHA105.570093","volume":"112","author":"L Mauri","year":"2005","unstructured":"Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE: Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation. 2005, 112: 2833-2839. 10.1161\/CIRCULATIONAHA105.570093.","journal-title":"Circulation"},{"key":"511_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jacc.2007.07.084","volume":"51","author":"SJ Pocock","year":"2008","unstructured":"Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, et al: Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol. 2008, 51: 23-32. 10.1016\/j.jacc.2007.07.084.","journal-title":"J Am Coll Cardiol"},{"key":"511_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1004130","volume":"363","author":"PW Serruys","year":"2010","unstructured":"Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, et al: Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med. 2010, 363: 136-146. 10.1056\/NEJMoa1004130.","journal-title":"N Engl J Med"},{"key":"511_CR36","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.amjcard.2010.01.007","volume":"105","author":"LO Jensen","year":"2010","unstructured":"Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Lassen JF, et al: Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark. Am J Cardiol. 2010, 105: 1513-1519. 10.1016\/j.amjcard.2010.01.007.","journal-title":"Am J Cardiol"},{"key":"511_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCINTERVENTIONS.110.959924","volume":"4","author":"C Briguori","year":"2011","unstructured":"Briguori C, Airoldi F, Visconti G, Focaccio A, Caiazzo G, Golia B, et al: Novel Approaches for Preventing or Limiting Events in Diabetic Patients (Naples-Diabetes) Trial: A Randomized Comparison of 3 Drug-Eluting Stents in Diabetic Patients. Circ Cardiovasc Interv. 2011, 4: 121-129. 10.1161\/CIRCINTERVENTIONS.110.959924.","journal-title":"Circ Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-12-84\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:32:11Z","timestamp":1548189131000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-12-84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-12-84","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,2]]},"article-number":"84"}}